Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease

Fig. 2

ROC curve associated with ability of CSF sSorlA levels to predict if a patient is carrier of a trafficking defective SORL1 variant. The ROC curve was obtained by computing sensitivity and specificity associated with different thresholds of CSF sSorlA levels to distinguish between patients in AD SORL1 TD group and patients in AD SORL1 nTD + AD SORL1 WT group

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193